Morrison Foerster is an international law firm with lawyers practicing throughout the United States, Asia, and Europe. Click to discover more.

mofo_share_image.jpg

Morrison Foerster

favicon.ico

favicon-16x16.png

favicon-32x32.png

apple-touch-icon.png

MoFo Favicons

Terms / Notices

Cookies

Privacy Policy

Attorney Advertising

Secure Login

Alumni

  Facebook

MoFo Facebook

  Linkedin

MoFo LinkedIN

Twitter

MoFo Twitter

YouTube

MoFo Youtube

Morrison Foerster - Footer

You have not solved the recaptcha challenge yet or session expired, try again.

Disclaimer

Unsolicited e-mails and information sent to Morrison Foerster will not be considered confidential, may be disclosed to others pursuant to our <a href="https://www.mofo.com/about/privacy-policy.html">Privacy Policy</a>, may not receive a response, and do not create an attorney-client relationship with Morrison Foerster. If you are not already a client of Morrison Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.

Feedback

mofo-logo-2022.svg

People

Capabilities

Resources

About

Culture

Offices

Careers

Stay Connected

This session will review key developments in IP law and their impact on patent strategy with a focus on precision medicine and immuno-oncology. The session will provide background and updates on patent eligibility (section 101), tradeoffs between eligibility and the ability to effectively sue infringers. In addition, discuss legal developments that impact patent strategy for antibody or TCR-based products.

IO Intellectual Property

This session will review key developments in IP law and their impact on patent strategy with a focus on precision medicine and immuno-oncology. The session will provide background and updates on patent eligibility (section 101), tradeoffs between eligibility and the ability to effectively sue infringers. In addition, discuss legal developments that impact patent strategy for antibody or TCR-based products.<hr>

Precision Medicine World Conference 2019

IO Intellectual Property

Sign Up

Catherine M. Polizzi

Partner

IO Intellectual Property - 506221771

IO Intellectual Property

21 Jan 2019 8:00 AM - 8:00 AM